List of insiders holdings for Q32 Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt III L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt HIF L.P. Possible Member of 10% Group 10% Owner | 2020-05-01 08:31:18 | 2,254,567 0 | 2,254,567 | Form 13D |
| 2 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2024-03-28 16:28:26 | 2,252,987 0 | 2,252,987 | Form 13D |
| 3 | Novartis Institutes for BioMedical Research Inc. NOVARTIS AG 10% Owner | 2020-03-10 12:20:08 | 1,979,226 0 | 1,979,226 | Form 13G |
| 4 | SHAH MAHENDRA Director | 2018-05-16 16:05:25 | 0 909,742 | 909,742 | Form 4/A |
| 5 | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 2024-04-01 21:52:41 | 864,261 0 | 864,261 | Form 13D |
| 6 | Vida Ventures LLC VV Manager LLC 10% Owner | 2018-04-04 16:24:00 | 0 770,845 | 770,845 | Form 4 |
| 7 | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 2018-04-04 16:24:07 | 0 645,845 | 645,845 | Form 4 |
| 8 | Chatterjee Saswati 10% Owner | 2018-03-27 18:02:57 | 475,014 0 | 475,014 | Form 3 |
| 9 | Temasek Holdings (Private) Ltd Fullerton Management Pte Ltd Temasek Life Sciences Private Ltd TLS Beta Pte. Ltd. V-Sciences Investments Pte Ltd 10% Owner | 2024-10-25 06:06:25 | 313,943 0 | 313,943 | Form 13G |
| 10 | Smith W Bradford See remarks | 2023-02-27 16:05:27 | 249,000 0 | 249,000 | Form 4 |
| 11 | Rasty Siyamak Chief Operating Officer | 2019-07-11 16:30:42 | 222,707 0 | 222,707 | Form 4 |
| 12 | Campagna Jason Chief Medical Officer | 2025-02-26 21:57:04 | 213,876 0 | 213,876 | Form 4 |
| 13 | Seymour Albert See Remarks | 2023-09-08 16:44:26 | 160,254 0 | 160,254 | Form 4 |
| 14 | Morrison Jodie Pope CEO | 2025-08-28 19:32:30 | 121,506 0 | 121,506 | Form 4 |
| 15 | Blum Michael Lee Chief Commercial Officer | 2023-02-27 16:05:45 | 121,000 0 | 121,000 | Form 4 |
| 16 | Violette Shelia M. Chief Scientific Officer | 2025-08-28 19:28:26 | 58,384 36,277 | 94,661 | Form 4 |
| 17 | Iwicki Mark T Director | 2025-02-26 21:57:57 | 70,371 0 | 70,371 | Form 4 |
| 18 | Lundberg Sven Ante Director | 2025-02-26 21:52:54 | 70,178 0 | 70,178 | Form 4 |
| 19 | Manke Isaac Director | 2025-02-27 06:05:43 | 53,410 0 | 53,410 | Form 4 |
| 20 | GRAYZEL DAVID S. Director | 2025-02-26 21:56:38 | 52,526 0 | 52,526 | Form 4 |
| 21 | Kalowski Lee CFO and President | 2025-08-28 19:20:44 | 49,010 0 | 49,010 | Form 4 |
| 22 | TZIANABOS ARTHUR Director | 2025-02-27 06:01:06 | 38,441 0 | 38,441 | Form 4 |
| 23 | Kelly Timothy P Chief Operating Officer | 2022-02-28 16:05:55 | 33,000 0 | 33,000 | Form 4 |
| 24 | GILLIS STEVEN Director | 2023-06-15 19:25:26 | 23,000 0 | 23,000 | Form 4 |
| 25 | Patterson Matthew R Director | 2023-06-15 18:33:36 | 23,000 0 | 23,000 | Form 4 |
| 26 | Poulton Jeffrey V. Director | 2023-06-15 18:09:39 | 23,000 0 | 23,000 | Form 4 |
| 27 | REICIN ALISE Director | 2023-06-15 18:04:26 | 23,000 0 | 23,000 | Form 4 |
| 28 | LAPORTE KATHLEEN Director | 2025-02-27 06:01:11 | 20,145 0 | 20,145 | Form 4 |
| 29 | Gregory Richard J. Director | 2022-06-17 16:05:48 | 18,000 0 | 18,000 | Form 4 |
| 30 | PARMAR KUSH Director | 2022-06-17 16:05:20 | 18,000 0 | 18,000 | Form 4 |
| 31 | Wheeler Cameron Director | 2019-06-11 19:33:33 | 0 15,580 | 15,580 | Form 4/A |
| 32 | Thistle Mary Director | 2025-02-26 21:56:14 | 12,767 0 | 12,767 | Form 4 |
| 33 | Xu Diyong Director | 2025-02-26 21:59:00 | 12,767 0 | 12,767 | Form 4 |
| 34 | Cohn Gabriel Chief Medical Officer | 2022-01-12 16:05:24 | 11,339 0 | 11,339 | Form 4 |
| 35 | Jordan Julie Chief Medical Officer | 2023-08-07 21:39:25 | 7,496 0 | 7,496 | Form 4 |
| 36 | Alloway Paul See Remarks | 2024-04-23 17:03:07 | 2,596 0 | 2,596 | Form 4 |
| 37 | Michaud Charles Jr See Remarks | 2024-04-23 17:00:03 | 927 0 | 927 | Form 4 |
| 38 | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 2024-11-14 17:46:10 | 0 0 | 0 | Form 13G |
| 39 | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH NELSEN ROBERT 10% Owner | 2024-05-13 17:34:55 | 0 0 | 0 | Form 13G |